Sterop

What Sterop does

Sterop is a Brussels-based, privately held pharmaceutical manufacturer founded in 1947. The firm operates with 51-100 employees and produces four distinct product categories: drugs, food supplements, medical devices, and hygiene products. Its positioning combines regulated pharmaceutical manufacturing with consumer health and hygiene categories, suggesting a hybrid model that serves both clinical/OTC pharmaceutical channels and broader consumer goods distribution. The company has functioned continuously for more than seven decades, indicating institutional resilience in regulated European manufacturing.

The company's underlying technology stack and specific formulation details are not disclosed in the source material, and its website content was unavailable at the time of capture (displaying a loading/verification page). As such, the precise production methods, the depth of in-house R&D versus contract manufacturing, and the regulatory certifications held (e.g., GMP, ISO 13485 for medical devices, CE marking) cannot be characterized from this input. The fact that medical devices and pharmaceuticals appear in the same portfolio implies multiple parallel regulatory regimes in operation across the EU.

Sterop's business model appears to be product manufacturing and sale across its four categories, but the source data does not specify pricing model, sales channels, customer segmentation, or revenue mechanics. There is no disclosed ownership structure, investor base, M&A history, management team, customer list, or partnership network in the input. Public, current-period revenue and operating-status information are also unavailable from the captured source, leaving the firmographic profile materially incomplete for any forward-looking financial modeling.

Name

Sterop

Website

https://sterop.be

Company type

Private

Founded year

1947

Headcount range

51–100 employees

Short description

Sterop is a Brussels-based, privately held pharmaceutical manufacturer founded in 1947, employing 51-100 staff to produce drugs, food supplements, medical devices, and hygiene products for European markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Sanitary Paper Product Manufacturing (322291)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers) (HLAHANAC)

akta.pro secondary industry

Protective Disposable Wear (Masks, Gloves, Shoe Covers, Hairnets) (CRADALAJ)

Keywords

• Pharmaceutical manufacturing
• Drug production
• Food supplements
• Medical devices
• Hygiene products

Headquarters

HQ city

Brussels

HQ country

Belgium

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D

Core offering

Sterop is a Belgian pharmaceutical manufacturer that produces and sells four distinct product categories: drugs, food supplements, medical devices, and hygiene products. Operating from Brussels since 1947 with 51-100 employees, the company manufactures these regulated health products for distribution through pharmaceutical and healthcare channels.

Differentiator

Problem solved

Functional benefit

Products and services

• Drugs (pharmaceutical medicines) Manufactured pharmaceutical drug products produced by Sterop in Brussels, Belgium, for distribution to pharmacies, hospitals, and healthcare wholesalers.
• Food supplements Manufactured dietary/food supplement products produced by Sterop in Brussels, Belgium, sold through B2B pharmacy and healthcare distribution channels.
• Medical devices Manufactured medical device products produced by Sterop in Brussels, Belgium, for healthcare B2B buyers.
• Hygiene products Manufactured hygiene products produced by Sterop in Brussels, Belgium, sold to B2B healthcare and pharmacy buyers.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights1 record

Regional players

• UCB: Major Belgian-headquartered pharmaceutical company. Comparable on geographic base (Belgium) and pharma manufacturing footprint, though UCB is significantly larger and focused on specialty therapeutics rather than generic injectables.
• Mithra Pharmaceuticals: Belgian-based pharmaceutical company focused on women's health and specialty products. Comparable on Belgium HQ and pharma manufacturing profile, though operating in a different therapeutic niche.

Broad incumbents

• Fresenius Kabi: Major European-headquartered supplier of injectable drugs, IV solutions, nutrition, and medical devices. Comparable product overlap (sterile injectables, hospital disposables) and competes for the same hospital procurement budgets as Sterop.
• Baxter International: Large multinational with deep injectable solutions and hospital products portfolio. Competes with Sterop in sterile injectables, IV fluids, and broader hospital-supply category.
• B. Braun: Global medical and pharmaceutical company with a substantial sterile injectable solutions, IV fluids, and medical device portfolio. Broad incumbent that competes with Sterop across injectable drugs, medical devices, and hospital hygiene categories.
• Stada Arzneimittel: European generics and specialty healthcare company with a broad portfolio including injectables, OTC, and consumer health. Overlaps with Sterop's drug and food-supplement/hygiene categories across European markets.
• Sandoz: Global generics division of Novartis producing generic injectable, oral, and biosimilar medicines. Directly competes with Sterop's generic drug portfolio and brings substantial scale advantage in European tenders.

Direct peers

• Aguettant: French specialty pharmaceutical manufacturer focused on sterile injectable solutions in ampoules and pre-filled syringes. Closely comparable to Sterop in product format (small-volume sterile injectables) and target customers (hospital pharmacy, anesthesia, ICU).
• Laboratoires Macors: European generic injectable manufacturer producing sterile ampoules and small-volume parenterals. Directly comparable to Sterop in dosage form, regulatory class, and European generic-supply positioning.

Others

• Steriline: European manufacturer of sterile packaging and containment solutions for injectable drugs. Adjacent ecosystem participant that supplies equipment/components into the same sterile injectable value chain Sterop operates in.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sterop